Home > News > Show Me A Sign
September 15th, 2005
Show Me A Sign
Joe Alper: Initial clinical trials with some of these apoptosis detectors have shown promise, and now investigators are bringing the power of nanotechnology to bear on this effort in order to create powerful systems that would ultimately be capable of both delivering an anti-tumor drug and monitoring, in real time, if it is triggering cell death. The development of a nanotechnology-enabled apoptosis detector is one of the strategic areas of emphasis of the NCI Alliance for Nanotechnology in Cancer.
Though this work is still in its early stages, its potential is a harbinger of things to come. "Having a real-time apoptosis detector would represent a significant advance in cancer therapy, one that would let us alter treatment to reflect how each patient responds to a given set of drugs soon after being given those drugs," remarked James Olson, M.D.
Air Forceís 30-year plan seeks 'strategic agility' August 1st, 2014
IBM Announces $3 Billion Research Initiative to Tackle Chip Grand Challenges for Cloud and Big Data Systems: Scientists and engineers to push limits of silicon technology to 7 nanometers and below and create post-silicon future July 10th, 2014
Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014
Local girl does good March 22nd, 2014
Nanoparticles Used to Improve Quality of Bone Cement September 29th, 2014
Teijin Aramidís carbon nanotube fibers awarded with Paul Schlack prize: New generation super fibers bring wave of innovations to fiber market September 25th, 2014
Nanotubes help healing hearts keep the beat: Rice University, Texas Childrenís Hospital patch for defects enhances electrical connections between cells September 23rd, 2014
Immune system is key ally in cyberwar against cancer: Rice University study yields new two-step strategy for weakening cancer September 23rd, 2014